2021 annual financial data
Definium Therapeutics 2021 Operating cash flow
Definium Therapeutics 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -45,824,000 USD.
Operating income was -93,854,000 USD and net income was -93,036,000 USD.
Operating cash flow was -45,824,000 USD.
Get free Definium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -93,854,000 USD
- Net income
- -93,036,000 USD
- Operating cash flow
- -45,824,000 USD